Literature DB >> 2545901

A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements.

J Fujisawa1, M Toita, M Yoshida.   

Abstract

The trans activator (p40tax) of human T-cell leukemia virus type I (HTLV-I) is a transcriptional factor that activates the long terminal repeat (LTR) of HTLV-I and interleukin-2 receptor alpha. We examined the HTLV-I enhancer responsible for tax-mediated trans activation and identified (A/T)(G/C)(G/C)CNNTGACG(T/A) as a plausible tax-responsive element (TRE). The putative TRE in the LTR was found to be different from the elements required for activation by cycle AMP and 12-O-tetradecanoylphorbol-13-acetate, although these elements overlapped each other. The TRE was also different from a binding site of an NF-kappa B-like factor that was identified in the interleukin-2 receptor alpha promoter and human immunodeficiency virus LTR as a TRE. The latter result was further demonstrated by the failure of the NF-kappa B sequence to compete with the TRE of the LTR in a protein-binding assay. These findings indicate that tax function and its cascade can modulate activities of various enhancer sequences, which are probably regulated by distinct DNA-binding factors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545901      PMCID: PMC250893          DOI: 10.1128/JVI.63.8.3234-3239.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I.

Authors:  M Seiki; J Inoue; M Hidaka; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

2.  Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product.

Authors:  S Ruben; H Poteat; T H Tan; K Kawakami; R Roeder; W Haseltine; C A Rosen
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

3.  In vitro transcription: whole-cell extract.

Authors:  J L Manley; A Fire; M Samuels; P A Sharp
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  A nuclear factor is required for transactivation of HTLV-I gene expression.

Authors:  R E Park; W A Haseltine; C A Rosen
Journal:  Oncogene       Date:  1988-09       Impact factor: 9.867

5.  Activation of T cell-derived lymphokine genes in T cells and fibroblasts: effects of human T cell leukemia virus type I p40x protein and bovine papilloma virus encoded E2 protein.

Authors:  S Miyatake; M Seiki; R D Malefijt; T Heike; J Fujisawa; Y Takebe; J Nishida; J Shlomai; T Yokota; M Yoshida
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

6.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation.

Authors:  J W Lowenthal; E Böhnlein; D W Ballard; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  Cell-line specific activation of SV40 transcriptional enhancer by p40tax of HTLV-1.

Authors:  J Fujisawa; M Seiki; M Toita; S Miyatake; K Arai; M Yoshida
Journal:  Jpn J Cancer Res       Date:  1988-07

10.  Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins.

Authors:  M Hidaka; J Inoue; M Yoshida; M Seiki
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  53 in total

1.  Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation.

Authors:  H A Giebler; J E Loring; K van Orden; M A Colgin; J E Garrus; K W Escudero; A Brauweiler; J K Nyborg
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.

Authors:  N Aoyama; T Nagase; T Sawazaki; G Mizuguchi; H Nakagoshi; J I Fujisawa; M Yoshida; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Characterization of the promoter region of the src family gene lyn and its trans activation by human T-cell leukemia virus type I-encoded p40tax.

Authors:  F Uchiumi; K Semba; Y Yamanashi; J Fujisawa; M Yoshida; K Inoue; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

4.  The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation.

Authors:  J Fujisawa; M Toita; T Yoshimura; M Yoshida
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Protein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeat.

Authors:  H T Poteat; F Y Chen; P Kadison; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Authors:  Nancy Dumais; Marie-Eve Paré; Simon Mercier; Salim Bounou; Susan J Marriot; Benoit Barbeau; Michel J Tremblay
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Transcriptional suppression of the human T-cell leukemia virus type I long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region.

Authors:  X Xu; D A Brown; I Kitajima; J Bilakovics; L W Fey; M I Nerenberg
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  Molecular cloning of a novel human cDNA encoding a zinc finger protein that binds to the interleukin-3 promoter.

Authors:  N Koyano-Nakagawa; J Nishida; D Baldwin; K Arai; T Yokota
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I.

Authors:  A Tsujimoto; H Nyunoya; T Morita; T Sato; K Shimotohno
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Complex formation between CREB and Tax enhances the binding affinity of CREB for the human T-cell leukemia virus type 1 21-base-pair repeats.

Authors:  M J Yin; R B Gaynor
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.